Acorda Therapeutics, Inc is a biotechnology business based in the US. Acorda Therapeutics shares (ACOR) are listed on the NASDAQ and all prices are listed in US Dollars. Acorda Therapeutics employs 167 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Acorda Therapeutics
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ACOR – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- ACOR shares summary
- Compare share dealing platforms
- Is ACOR stock a buy or sell?
- Stock performance over time
- Can I short ACOR shares?
- Are ACOR shares over-valued?
- Acorda Therapeutics's financials
- How volatile are ACOR shares?
- Does Acorda Therapeutics pay a dividend?
- Have ACOR shares ever split?
- Other common questions
Acorda Therapeutics stock price (NASDAQ: ACOR)Use our graph to track the performance of ACOR stocks over time.
Acorda Therapeutics shares at a glance
|Latest market close||$3.72|
|52-week range||$2.53 - $8.66|
|50-day moving average||$4.26|
|200-day moving average||$5.13|
|Wall St. target price||$10.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$6.13|
Buy Acorda Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Acorda Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Acorda Therapeutics price performance over time
|1 week (2021-07-14)||N/A|
|1 month (2021-06-25)||-28.32%|
|3 months (2021-04-21)||N/A|
|6 months (2021-01-21)||N/A|
|1 year (2020-07-21)||N/A|
|2 years (2019-07-21)||N/A|
|3 years (2018-07-21)||N/A|
|5 years (2016-07-21)||N/A|
Is Acorda Therapeutics under- or over-valued?
Valuing Acorda Therapeutics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Acorda Therapeutics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Acorda Therapeutics's PEG ratio
Acorda Therapeutics's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.51. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Acorda Therapeutics's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Acorda Therapeutics financials
|Revenue TTM||$153.7 million|
|Gross profit TTM||$96.8 million|
|Return on assets TTM||-7.64%|
|Return on equity TTM||-49.35%|
|Market capitalisation||$43.7 million|
TTM: trailing 12 months
Shorting Acorda Therapeutics shares
There are currently 675,629 Acorda Therapeutics shares held short by investors – that's known as Acorda Therapeutics's "short interest". This figure is 15% down from 794,667 last month.
There are a few different ways that this level of interest in shorting Acorda Therapeutics shares can be evaluated.
Acorda Therapeutics's "short interest ratio" (SIR)
Acorda Therapeutics's "short interest ratio" (SIR) is the quantity of Acorda Therapeutics shares currently shorted divided by the average quantity of Acorda Therapeutics shares traded daily (recently around 414496.3190184). Acorda Therapeutics's SIR currently stands at 1.63. In other words for every 100,000 Acorda Therapeutics shares traded daily on the market, roughly 1630 shares are currently held short.
However Acorda Therapeutics's short interest can also be evaluated against the total number of Acorda Therapeutics shares, or, against the total number of tradable Acorda Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Acorda Therapeutics's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Acorda Therapeutics shares in existence, roughly 60 shares are currently held short) or 0.089% of the tradable shares (for every 100,000 tradable Acorda Therapeutics shares, roughly 89 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Acorda Therapeutics.
Find out more about how you can short Acorda Therapeutics stock.
Acorda Therapeutics share dividends
We're not expecting Acorda Therapeutics to pay a dividend over the next 12 months.
Have Acorda Therapeutics's shares ever split?
Acorda Therapeutics's shares were split on a 1:6 basis on 3 January 2021. So if you had owned 6 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Acorda Therapeutics shares – just the quantity. However, indirectly, the new 500% higher share price could have impacted the market appetite for Acorda Therapeutics shares which in turn could have impacted Acorda Therapeutics's share price.
Acorda Therapeutics share price volatility
Over the last 12 months, Acorda Therapeutics's shares have ranged in value from as little as $2.5344 up to $8.66. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Acorda Therapeutics's is 0.6736. This would suggest that Acorda Therapeutics's shares are less volatile than average (for this exchange).
Acorda Therapeutics overview
Acorda Therapeutics, Inc. , a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); Selincro for the treatment of alcohol dependence; and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops ARCUS product for the treatment of acute migrain; rHIgM22, which has completed Phase I clinical trial for the treatment of MS; and Cimaglermin alfa for heart failure patients. The company has collaboration and license agreement with Biogen Inc. for the development and commercialization of Ampyra.
Stocks similar to Acorda Therapeutics
Acorda Therapeutics in the news
Acorda Therapeutics Continues To Maneuver For A Turnaround
50 Stocks Moving In Friday's Mid-Day Session
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Frequently asked questionsWhat percentage of Acorda Therapeutics is owned by insiders or institutions?
Currently 1.847% of Acorda Therapeutics shares are held by insiders and 40.048% by institutions. How many people work for Acorda Therapeutics?
Latest data suggests 167 work at Acorda Therapeutics. When does the fiscal year end for Acorda Therapeutics?
Acorda Therapeutics's fiscal year ends in December. Where is Acorda Therapeutics based?
Acorda Therapeutics's address is: 420 Saw Mill River Road, Ardsley, NY, United States, 10502 What is Acorda Therapeutics's ISIN number?
Acorda Therapeutics's international securities identification number is: US00484M1062 What is Acorda Therapeutics's CUSIP number?
Acorda Therapeutics's Committee on Uniform Securities Identification Procedures number is: 00484M106
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert